Basic info
Industry
biotechnology research
Sectors
Biotechnology
immune modelling
tissue damage
disease mechanisms
human cells
immunogenicity
immunotox
Health Care
mathematical modelling
immune response
cell culture
preclinical
protein biology
in vitro
immune markers
mass spectrometry
in vivo
flow cytometry
immunohistochemistry
immunology
cell characterisation
Date founded
2016
Funding rounds raised
Total raised
$82K
from 1 investors over 1 rounds
I
Immundnz Ltd raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)